[Experimental results of the combined treatment of parkinsonism using L-DOPA and a decarboxylase inhibitory agent (Ro 4-4602)].
D000368:Aged; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004357:Drug Synergism; D004794:Enzyme Repression; D006801:Humans; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases
Experimentelle Ergebnisse über die Kombinationsbehandlung des Parkinson-Syndroms mit L-DOPA und einem Decarboxylasehemmer (Ro 4-4602)